In this week’s episode of Tort Talk, Joe Fantini joins Jon and Marc to break down the latest developments in mass tort litigation:Uber MDL: Over 2,500 cases consolidated, with the first bellwether trial set for December 2025. We discuss Uber’s defense tactics and the spectrum of claims moving forward.Bard PowerPort: 1,800+ cases pending, with the first bellwether trial expected in early 2026. Key Daubert rulings are on the horizon.GLP-1 Weight Loss Drugs (Ozempic, Wegovy, Mounjaro, etc.): New rulings clarify proof requirements for gastroparesis claims, reshaping the litigation landscape.PFAS “Forever Chemicals”: CMO 35 sets critical deadlines before September 5th, including case bundling options and proof requirements for top-tier injuries.From bellwether trials to major rulings, we cover the most important updates for firms, claimants, and anyone following mass tort litigation.